CoSyne Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Later Stage VC
- Investors
-
13
CoSyne Therapeutics General Information
Description
Operator of an AI-powered drug discovery company designed to accelerate the development of precision medicines for brain diseases. The company utilizes polymathic artificial intelligence and vertically integrated research processes to identify and develop therapeutic candidates, enabling healthcare providers to treat patients with underserved neurological conditions and brain cancer more effectively.
Contact Information
Website
www.cosyne.comCorporate Office
- 2 Sheraton Street
- WeWork Medius House
- London W1F 8BH
- England, United Kingdom
Corporate Office
- 2 Sheraton Street
- WeWork Medius House
- London W1F 8BH
- England, United Kingdom
CoSyne Therapeutics Timeline
CoSyne Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 01-Jan-2026 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 08-Aug-2024 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 20-May-2022 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 03-Sep-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
CoSyne Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 Preferred | ||||||||
| Seed Preferred | ||||||||
| Seed Preferred | ||||||||
| Ordinary | 15,470 | $0.000013 | $4.37 | $4.37 | 1x | $4.37 | 0.24% | |
| Ordinary | 268,537 | $0.000013 | $3.46 | $3.46 | 1x | $3.46 | 4.22% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CoSyne Therapeutics Patents
CoSyne Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025158382-A1 | Vector compositions for guide nucleic acid delivery and uses thereof | Pending | 26-Jan-2024 | ||
| WO-2025104702-A1 | Perturbation-linked genetic profile analysis | Inactive | 17-Nov-2023 | ||
| WO-2025022355-A1 | Methods of barcoding single cells and cellular subpopulations and uses thereof | Inactive | 25-Jul-2023 | ||
| WO-2024161359-A2 | Compound representation and property analysis at scale | Inactive | 01-Feb-2023 | ||
| WO-2024161359-A3 | Compound representation and property analysis at scale | Inactive | 01-Feb-2023 | G16C20/30 |
CoSyne Therapeutics Signals
CoSyne Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arc Ventures (United States) | Venture Capital | Minority | ||
| B&Y Venture Partners | Venture Capital | Minority | ||
| Montage Ventures | Venture Capital | Minority | ||
| Amino Collective | Venture Capital | Minority | ||
| Backed | Venture Capital | Minority |
CoSyne Therapeutics FAQs
-
When was CoSyne Therapeutics founded?
CoSyne Therapeutics was founded in 2021.
-
Where is CoSyne Therapeutics headquartered?
CoSyne Therapeutics is headquartered in London, United Kingdom.
-
What is the size of CoSyne Therapeutics?
CoSyne Therapeutics has 16 total employees.
-
What industry is CoSyne Therapeutics in?
CoSyne Therapeutics’s primary industry is Drug Discovery.
-
Is CoSyne Therapeutics a private or public company?
CoSyne Therapeutics is a Private company.
-
What is CoSyne Therapeutics’s current revenue?
The current revenue for CoSyne Therapeutics is .
-
How much funding has CoSyne Therapeutics raised over time?
CoSyne Therapeutics has raised $13M.
-
Who are CoSyne Therapeutics’s investors?
Arc Ventures (United States), B&Y Venture Partners, Montage Ventures, Amino Collective, and Backed are 5 of 13 investors who have invested in CoSyne Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process